NCT06101459View on ClinicalTrials.gov

A Study About Association Between Microbiome, Metabolome and Clinical Characteristics in COPD Patients

Not yet recruitingOBSERVATIONAL
Enrollment

300

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

June 30, 2028

Study Completion Date

December 31, 2028

Conditions
Chronic Obstructive Pulmonary Disease
Sponsors

Collaborators (1)

HEM Pharma Inc.
All Listed Sponsors
collaborator

Seoul National University College of Medicine

UNKNOWN

collaborator

HEM Pharma Inc.

INDUSTRY

lead

Asan Medical Center

OTHER

NCT06101459 - A Study About Association Between Microbiome, Metabolome and Clinical Characteristics in COPD Patients | Biotech Hunter | Biotech Hunter